Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Objective: Evaluate the use of tranexamic acid (TXA) and observation as a management option for pediatric patients presenting with posttonsillectomy hemorrhage (PTH).
Study Design: Retrospective analysis of a prospectively implemented quality improvement initiative with a historical control comparison group.
Setting: Tertiary children's hospital.
Methods: Patients <18 years of age who underwent adenotonsillectomy (AT) and returned to the Emergency Department for PTH were included. Patients who were stable without large volume or active bleeding were given intravenous TXA and admitted for overnight observation. Data were compared in a before-and-after analysis: preprotocol (April 2022 to March 2023) versus postprotocol (April 2023 to March 2024). For cost-effectiveness analysis, we analyzed aggregated claims data from a commercial claims database.
Results: Preprotocol 1800 adenotonsillectomies were performed, and 40 procedures were performed for control of hemorrhage (2.2 per 100 AT). Postprotocol 2356 adenotonsillectomies were performed, and 30 procedures were performed to control hemorrhage (1.3 per 100 AT) showing a significant reduction in return to the operating room (relative risk [RR] = 0.59, 95% confidence interval [CI] [0.358, 0.916], P-value .020). There were no reported adverse events attributable to TXA. An estimated 21 surgeries were avoided, and 26 additional patients were observed in the hospital during the postprotocol period, for an estimated net cost savings of $174,970.
Conclusion: The implementation of a standardized TXA protocol significantly reduced the need for return to the operating room for PTH in pediatric patients, without complications and with net cost savings to the healthcare system.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12379852 | PMC |
| http://dx.doi.org/10.1002/ohn.1300 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Post-tonsillectomy risks in patients with Ehlers-Danlos syndrome.
Int J Pediatr Otorhinolaryngol
September 2025
Department of Otolaryngology - Head & Neck Surgery, University of Colorado School of Medicine, Aurora, CO, USA; Department of Otolaryngology, Children's Hospital of Colorado, Aurora, CO, USA. Electronic address:
Introduction: There is a paucity of data on the connective tissue disorder causing delayed wound healing in children with Ehlers Danlos Syndrome (EDS), potentially affecting the rates of post-tonsillectomy hemorrhage (PTH) following tonsillectomy and adenotonsillectomy (T&A). Understanding the postoperative course of this population could provide better guidance in their postoperative management which formed the basis of our study.
Methods: This was a retrospective chart review in an academic pediatric center that compared the PTH rates between patients with EDS and control children.
Corrigendum to "Predictive value of preoperative neutrophil-to-lymphocyte ratio for post-tonsillectomy hemorrhage: Age-Specific insights from a pediatric cohort" [Int. J. Pediatr. Otorhinolaryngol. 196 (2025) 112480].
Int J Pediatr Otorhinolaryngol
August 2025
Department of Otolaryngology - Head and Neck Surgery, Atlas University, Istanbul, Turkey.
Objective: To evaluate the predictive value of preoperative neutrophil-to-lymphocyte ratio (NLR) for postoperative hemorrhage following pediatric tonsillectomy and to explore its age-specific performance.
Methods: This retrospective study included 100 pediatric patients who underwent tonsillectomy at a single tertiary center between January 2021 and December 2025. Fifty patients with postoperative hemorrhage and 50 without bleeding were analyzed.
Tranexamic Acid for Preventing Secondary Post-Tonsillectomy Bleeding: Insights From A Retrospective Cohort Study.
Clin Ther
July 2025
Department of Otorhinolaryngology, Head and Neck Surgery, Hamad Medical Corporation, Doha, Qatar.
Purpose: Post-tonsillectomy bleeding (PTB) is the leading cause of re-operation and mortality following tonsillectomy. Tranexamic acid (TXA) has been widely utilized in various medical fields to manage bleeding. However, its efficacy in preventing bleeding after tonsillectomy remains uncertain.
View Article and Find Full Text PDFAssociation between Systemic Immune-Inflammation Index (SII) and secondary haemorrhage risk after tonsillectomy.
J Laryngol Otol
July 2025
Department of Otolaryngology Head and Neck Surgery, University of Health Sciences, Izmir Tepecik Training and Research Hospital, Izmir, Turkey.
Objectives: This study evaluates the relationship between Systemic Immune-Inflammation Index and secondary tonsillar haemorrhage after tonsillectomy.
Methods: Sixty pediatric patients with secondary haemorrhage and 60 without bleeding were grouped for comparative analysis. Laboratory parameters and Systemic Immune-Inflammation Index values were collected preoperatively, on the bleeding day and on the control day, then compared.
Return to theatre for post-tonsillectomy haemorrhage in children has not fallen with increased use of plasma ablation tonsillectomy: a retrospective analysis of 359,241 tonsillectomies in 15 years of United Kingdom Hospital Episode Statistics.
PLoS One
July 2025
Department of Ear, Nose and Throat Surgery, University Hospitals Birmingham NHS Foundation Trust, Mindelsohn Way, Edgbaston, Birmingham, United Kingdom.
Introduction: Plasma ablation tonsillectomy has rapidly increased in popularity and is now the most popular technique in children. This study aims to evaluate the impact of plasma ablation tonsillectomy on the incidence of post-operative haemorrhage requiring surgical intervention in children, a complication affecting patient safety and healthcare resource utilisation.
Methods: 15 years (2009/10-2023/24) of Hospital Episode Statistics for children 14 years or under, capturing all tonsillectomies in NHS England hospitals was analysed.